Organovo Holdings Inc (NYSEMKT: ONVO)

Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company’s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. The company was founded in 2007 and is based in San Diego, California.
Please take a look at the 1-year chart of ONVO (Organovo Holdings) below with my added notations:

Overall ONVO has done quite well over the last 12 months having gone from a low of almost $3 to a high of over $13. The two most common price levels on this stock during the 3 months have been $8 (blue) and $10 (red). Each of those prices has been both support and resistances multiple times. In addition, $12 was hit as resistance on 3 different occasions in January. So, the stock commonly finds the increments of $2 important.

The Tale of the Tape: ONVO is currently trading between $8 and $10. A long trade could be made on a pullback to $8 or on a break back above $10. Short trades could be made on a rally up to $10 or on a break below $8.
Please share this article